Side effects of drugs annual 33 : a worldwide yearly survey of new data in adverse drug reactions / editor, J.K. Aronson.

Format:

Book

Contributor:

Aronson, J. K.

Series:

Side effects of drugs annual, 0378-6080 ; v. 33

Language:

English

Subjects (All):

Drugs--Side effects.

Drugs.

Pharmacology.

Physical Description:

1 online resource (1152 p.)

Edition:

1st ed.

Place of Publication:

Amsterdam : Elsevier, 2011.

Language Note:

English

Summary:

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading. Each new Annual continues to p

Contents:

Front Cover; A worldwide yearly survey of new data inadverse drug reactions; Copyright; Contributors; Contents; Special reviews; Cumulative indexes of specialreviews, Annuals 11-32; 1. Index of drugs; 2. Index of adverse reactions; Table of Essays, Annuals 1-32; Mechanistic and clinicaldescriptions ofadverse drug reactions; 1. EIDOS; 2. DoTS; References; How to use this book; The scope of the Side Effects of Drugs Annuals; Period covered; Selection of material; Special reviews; Classification of drugs; Names of drugs and chemicals; System of tagging references; Indexes; Abbreviations

Third-generationoral contraceptives:time to look again?Three generations; Renewed concern; Profiling the risk; A fourth generation?; The defenders; The view today; Conclusions; Acknowledgements; References; Chapter 1: Central nervous system stimulants and drugs that suppress appetite; Amphetamines [SED-15, 180; SEDA-30, 1; SEDA-31, 1; SEDA-32, 1]; Amfetamine and dexamfetamine [SEDA-30, 1; SEDA-32, 1]; Systematic reviews; Cardiovascular; Death; Susceptibility factors; Genetic; Drug overdose; Ecstasy (3,4-methylenedioxymetamfetamine, MDMA); Metamfetamine [SEDA-30, 2; SEDA-31, 1

SEDA-32, 3]Cardiovascular; Nervous system; Gastrointestinal; Drug abuse; Teratogenicity; Fenfluramines [SED-15, 1333; SEDA-30, 7; SEDA-32, 7]; Cardiovascular; Hematologic; Atomoxetine; Observational studies; Systematic reviews; Cardiovascular; Nervous system; Sensory systems; Psychiatric; Teeth; Drug-drug interactions; Methylphenidate; Susceptibility factors; Methylphenidate [SED-15, 2307; SEDA-30, 4; SEDA-3, 3; SEDA-32, 10]; Observational studies; Comparative studies; Placebo-controlled trials; Systematic reviews; Psychiatric; Urinary tract; Skin; Genotoxicity; Susceptibility factors

GeneticDrug-drug interactions; Fluoxetine; Modafinil [SED-15, 2369; SEDA-30, 6; SEDA-31, 7; SEDA-32, 6]; Observational studies; Placebo-controlled studies; Psychiatric; Methylxanthines; Caffeine [SED-15, 588; SEDA-30, 5; SEDA-31, 8; SEDA-32, 14]; Teratogenicity; Drug overdose; Theophylline [SED-15, 3361; SEDA-30, 5; SEDA-31, 8; SEDA-32, 15]; Nervous system; Drug overdose; Drugs that suppress appetite [SEDA-30, 7; SEDA-31, 9; SEDA-32, 16]; Phentermine [SED-15, 2804; SEDA-31, 9; SEDA-32, 17]; Cardiovascular; Sibutramine [SED-15, 3131; SEDA-30, 7; SEDA-31, 9; SEDA-32, 17]

CardiovascularSusceptibility factors; Genetic; Rimonabant [SEDA-32, 19]; Systematic reviews; Cardiovascular; Nervous system; Psychological; Drug-drug interactions; Ciclosporin; Tesofensine; Placebo-controlled studies; Drugs used in Alzheimer's disease [SEDA-30, 8; SEDA-31, 10; SEDA-32, 19]; Observational study; Donepezil [SED-15, 1179; SEDA-30, 8; SEDA-31, 10; SEDA-32, 19]; Observational studies; Placebo-controlled studies; Huperzine; Systematic reviews; Memantine [SED-15, 2250; SEDA-32, 20]; Rivastigmine [SED-15, 3072; SEDA-30, 10; SEDA-31, 11; SEDA-32, 20]; Observational studies

Systematic reviews

Notes:

Description based upon print version of record.

Includes bibliographical references and indexes.

ISBN:

1-283-34817-9

9786613348173

0-444-53742-2

OCLC:

775871930